Amundi
DGX icon

Amundi’s Quest Diagnostics DGX Stock Holding History

Amundi’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80M Sell
408,330
-55,834
-12% -$10.8M 0.02% 490
2025
Q4 		$80.5M Buy
464,164
+36,610
+9% +$6.67M 0.02% 532
2025
Q3 		$76.3M Sell
427,554
-16,008
-4% -$2.84M 0.02% 464
2025
Q2 		$78.3M Sell
443,562
-136,791
-24% -$23.8M 0.03% 468
2025
Q1 		$99M Sell
580,353
-215,132
-27% -$35.3M 0.04% 399
2024
Q4 		$123M Buy
795,485
+77,559
+11% +$12.1M 0.04% 380
2024
Q3 		$107M Sell
717,926
-179,564
-20% -$26.8M 0.04% 386
2024
Q2 		$126M Buy
897,490
+332,965
+59% +$45.6M 0.05% 324
2024
Q1 		$71.1M Buy
564,525
+142,672
+34% +$18.5M 0.03% 445
2023
Q4 		$59.9M Buy
421,853
+18,417
+5% +$2.42M 0.03% 496
2023
Q3 		$49.4M Sell
403,436
-303,965
-43% -$40.5M 0.02% 515
2023
Q2 		$98.8M Sell
707,401
-563,766
-44% -$77.7M 0.05% 361
2023
Q1 		$181M Sell
1,271,167
-204,187
-14% -$29.2M 0.1% 236
2022
Q4 		$229M Buy
1,475,354
+105,471
+8% +$15.2M 0.13% 187
2022
Q3 		$170M Buy
1,369,883
+206,992
+18% +$27.3M 0.1% 219
2022
Q2 		$155M Sell
1,162,891
-150,119
-11% -$20.5M 0.12% 184
2022
Q1 		$180M Sell
1,313,010
-306,291
-19% -$42.7M 0.12% 191
2021
Q4 		$261M Sell
1,619,301
-30,184
-2% -$4.59M 0.17% 150
2021
Q3 		$240M Sell
1,649,485
-54,576
-3% -$7.99M 0.17% 151
2021
Q2 		$225M Buy
+1,704,061
New +$223M 0.16% 157

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Amundi's DGX Position: Q1 2026 in Review

Amundi reduced its Quest Diagnostics (DGX) stake by 12% in Q1 2026, selling an estimated $10.8M and leaving 408,330 shares worth $80M. The position accounts for 0.02% of the portfolio, ranked #490.

Amundi first reported a position in DGX in Q2 2021 and has held it in 20 quarters since. The position peaked at $261M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Amundi held 408,330 shares of Quest Diagnostics worth $80M as of Q1 2026.
  • Amundi sold 55,834 Quest Diagnostics shares in Q1 2026, an estimated $10.8M.
  • Quest Diagnostics made up 0.02% of Amundi's portfolio in Q1 2026, its #490 holding.
  • Amundi first reported a position in Quest Diagnostics in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Quest Diagnostics position peaked at $261M in Q4 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.